LumiraDx Limited

    LumiraDx Limited

    NNASDAQ:LMDX
    0.02
    USD
    0.00
    (0.00%)
    No data availableFinancial data will appear here once available

    Capital Structure

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Working Capital

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Growth Rates

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Quarterly Revenue

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Quarterly Earnings Per Share

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Quarterly Dividends Per Share

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Company Description

    Address
    Similar Companies
    Business

    Company News

    • AssureCKD Appoints Former LumiraDx Technical Director Dr. Aman Khan as Chief Technology Officer to Lead Diagnostic Platform Development

    • Former Alere and LumiraDx R&D Chief Nigel Lindner Joins CLEU Diagnostics to Launch Revolutionary LabSimple Diagnostic Platform

    • Why Is LumiraDx (LMDX) Stock Down 13% Today?

    • LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th

    • Roche to buy part of LumiraDx diagnostics platform for $295 million

    • LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche

    • Best Penny Stocks Today? 3 To Watch Under $4 Now

    • Penny Stocks To Buy? 4 Under $5 To Watch Right Now

    • LumiraDx Announces Receipt of NASDAQ Delisting Determination; Plans to Appeal

    • Why Is LumiraDx (LMDX) Stock Down 35% Today?

    • Why Is LumiraDx (LMDX) Stock Up 323% Today?

    • Top 4 Health Care Stocks That May Rocket Higher This Month - Generation Bio (NASDAQ:GBIO), Evelo Biosciences (NASDAQ:EVLO)

    • LumiraDx Limited (LMDX) Loses -25.54% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

    • What Makes LumiraDx Limited (LMDX) a New Buy Stock

    • LumiraDx Limited (LMDX) Q2 2023 Earnings Call Transcript

    • LumiraDx Limited (LMDX) Reports Q2 Loss, Misses Revenue Estimates

    • LumiraDx Reports Second Quarter 2023 Results

    • LumiraDx to Announce Second Quarter Financial Results and Host Quarterly Conference Call on August 24

    • LumiraDx's Point of Care Diagnostics Group Continues Commercial Expansion Announcing a Distribution Agreement with Axonlab for its LumiraDx Platform and Tests

    • Why Is LumiraDx (LMDX) Stock Up 30% Today?